Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children

Helicobacter pylori is an important risk factor for chronic gastritis, peptic ulcer, and gastric cancer. Three-drug regimen is the first-line treatment for this infection, but the response rate to treatment varies in different geographical regions. This study was conducted to comparatively determine...

Full description

Bibliographic Details
Main Authors: Karam-Ali Kasiri, Abolfazl Khoshdel, Afshin Karimi, Morteza Sedehi, Niloufar Kasiri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Advanced Pharmaceutical Technology & Research
Subjects:
Online Access:http://www.japtr.org/article.asp?issn=2231-4040;year=2017;volume=8;issue=2;spage=63;epage=66;aulast=Kasiri
_version_ 1828396352169574400
author Karam-Ali Kasiri
Abolfazl Khoshdel
Afshin Karimi
Morteza Sedehi
Niloufar Kasiri
author_facet Karam-Ali Kasiri
Abolfazl Khoshdel
Afshin Karimi
Morteza Sedehi
Niloufar Kasiri
author_sort Karam-Ali Kasiri
collection DOAJ
description Helicobacter pylori is an important risk factor for chronic gastritis, peptic ulcer, and gastric cancer. Three-drug regimen is the first-line treatment for this infection, but the response rate to treatment varies in different geographical regions. This study was conducted to comparatively determine the effect of amoxicillin and metronidazole on three-drug regimen to treat H. pylori infection in 1–15-year-old children. This clinical trial was conducted on 82 patients aged 1–15 years with convenience sampling referring to the Endoscopy Unit of Hajar Hospital, Shahrekord. Group 1 was administered with clarithromycin, amoxicillin, and omeprazole (CAO), and Group 2 with, clarithromycin, metronidazole, and omeprazole (CMO). One month after completion of the treatment, stool antigen test was used to study the eradication of H. pylori. Data were analyzed using SPSS software by Chi-square test. Three of the 82 patients were excluded from the study because of side effects caused by drugs. Nearly 87.2% of the patients in CAO-treated group and 92.5% in CMO-treated group had response to treatment. There was no significant difference in eradication rate between the two regimens (P = 0.43). The two regimens displayed no superiority over each other for eradicating H. pylori infection and response rate to treatment in children aged 1–15 years.
first_indexed 2024-12-10T08:28:33Z
format Article
id doaj.art-f2e4409e8f8e47a48db9f82c4b5db04c
institution Directory Open Access Journal
issn 2231-4040
0976-2094
language English
last_indexed 2024-12-10T08:28:33Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Advanced Pharmaceutical Technology & Research
spelling doaj.art-f2e4409e8f8e47a48db9f82c4b5db04c2022-12-22T01:56:10ZengWolters Kluwer Medknow PublicationsJournal of Advanced Pharmaceutical Technology & Research2231-40400976-20942017-01-0182636610.4103/japtr.JAPTR_162_16Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in childrenKaram-Ali KasiriAbolfazl KhoshdelAfshin KarimiMorteza SedehiNiloufar KasiriHelicobacter pylori is an important risk factor for chronic gastritis, peptic ulcer, and gastric cancer. Three-drug regimen is the first-line treatment for this infection, but the response rate to treatment varies in different geographical regions. This study was conducted to comparatively determine the effect of amoxicillin and metronidazole on three-drug regimen to treat H. pylori infection in 1–15-year-old children. This clinical trial was conducted on 82 patients aged 1–15 years with convenience sampling referring to the Endoscopy Unit of Hajar Hospital, Shahrekord. Group 1 was administered with clarithromycin, amoxicillin, and omeprazole (CAO), and Group 2 with, clarithromycin, metronidazole, and omeprazole (CMO). One month after completion of the treatment, stool antigen test was used to study the eradication of H. pylori. Data were analyzed using SPSS software by Chi-square test. Three of the 82 patients were excluded from the study because of side effects caused by drugs. Nearly 87.2% of the patients in CAO-treated group and 92.5% in CMO-treated group had response to treatment. There was no significant difference in eradication rate between the two regimens (P = 0.43). The two regimens displayed no superiority over each other for eradicating H. pylori infection and response rate to treatment in children aged 1–15 years.http://www.japtr.org/article.asp?issn=2231-4040;year=2017;volume=8;issue=2;spage=63;epage=66;aulast=KasiriAmoxicillinclarithromycinHelicobacter pylorimetronidazoleomeprazole
spellingShingle Karam-Ali Kasiri
Abolfazl Khoshdel
Afshin Karimi
Morteza Sedehi
Niloufar Kasiri
Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
Journal of Advanced Pharmaceutical Technology & Research
Amoxicillin
clarithromycin
Helicobacter pylori
metronidazole
omeprazole
title Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
title_full Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
title_fullStr Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
title_full_unstemmed Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
title_short Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
title_sort comparison of amoxicillin and metronidazole effect on three drug regimen for the treatment of helicobacter pylori infection in children
topic Amoxicillin
clarithromycin
Helicobacter pylori
metronidazole
omeprazole
url http://www.japtr.org/article.asp?issn=2231-4040;year=2017;volume=8;issue=2;spage=63;epage=66;aulast=Kasiri
work_keys_str_mv AT karamalikasiri comparisonofamoxicillinandmetronidazoleeffectonthreedrugregimenforthetreatmentofhelicobacterpyloriinfectioninchildren
AT abolfazlkhoshdel comparisonofamoxicillinandmetronidazoleeffectonthreedrugregimenforthetreatmentofhelicobacterpyloriinfectioninchildren
AT afshinkarimi comparisonofamoxicillinandmetronidazoleeffectonthreedrugregimenforthetreatmentofhelicobacterpyloriinfectioninchildren
AT mortezasedehi comparisonofamoxicillinandmetronidazoleeffectonthreedrugregimenforthetreatmentofhelicobacterpyloriinfectioninchildren
AT niloufarkasiri comparisonofamoxicillinandmetronidazoleeffectonthreedrugregimenforthetreatmentofhelicobacterpyloriinfectioninchildren